Pillstats
Rx only · Capsule, Delayed Release · Oral

Verapamil Hydrochloride

Verapamil Hydrochloride

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US4 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)11170
US makers1 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.06$2.13$3.19$4.26Dec 2025Apr 2026Jul 2026
$3.100
Latest avg · Jul 22, 2026
-8%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

n/a2.8K5.6K8.4K11K2025 Q12025 Q22025 Q32025 Q42026 Q1
9.7K
Rx · 2026 Q1
499K
Units dispensed
4
Quarters · since 2025 Q2

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Wilshire Pharmaceuticals, Inc.unknown4SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.